Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C53447
http://purl.obolibrary.org/obo/NCIT_C53447
|
|---|---|
| Preferred Name | Octreotide Acetate |
| Definitions |
The acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | The acetate salt of a synthetic long-acting cyclic octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Octreotide is a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Similar to somatostatin, this agent also suppresses the luteinizing hormone response to gonadotropin-releasing hormone, decreases splanchnic blood flow, and inhibits the release of serotonin, gastrin, vasoactive intestinal peptide (VIP), secretin, motilin, pancreatic polypeptide, and thyroid stimulating hormone. |
|---|---|
| prefLabel | Octreotide Acetate
|
| label | Octreotide Acetate
|
| PDQ_Closed_Trial_Search_ID | 38866
|
| code | C53447
|
| prefixIRI | NCIT:C53447
|
| in_subset |
See more
See less
|
| Display_Name | Octreotide Acetate
|
| Preferred_Name | Octreotide Acetate
|
| FDA_UNII_Code | 75R0U2568I
|
| Contributing_Source |
CTRP
FDA
|
| Chemical_Formula | C49H66N10O10S2.C2H4O2
|
| Maps_To | Octreotide Acetate
|
| CAS_Registry | 79517-01-4
|
| NSC Number | 671663
|
| NCI_Drug_Dictionary_ID | 38866
|
| Legacy Concept Name | Octreotide_Acetate
|
| Has_Free_Acid_Or_Base_Form | |
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 38866
|
| Accepted_Therapeutic_Use_For | Acromegaly; Diarrhea
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C0678117
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |